Editorial

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

Huntington’s Gene Therapy Moves Back Toward the FDA Door

G7 Cancer Call and WHA Precision Medicine Resolution: A Moment to Turn Ambition Into Delivery

Alzheimer’s Research Moves Beyond Amyloid

Ebola in Congo’s Camps Shows the Human Cost of Lost Trust

Pregnancy Vaccines Become a Trust Test as Medical Societies Step In

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
